XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
330 hedge funds and large institutions have $9.13B invested in Acceleron Pharma in 2021 Q3 according to their latest regulatory filings, with 96 funds opening new positions, 86 increasing their positions, 105 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
22% more funds holding
Funds holding: 270 → 330 (+60)
18% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 105
Holders
330
Holding in Top 10
13
Calls
$578M
Puts
$195M
Top Buyers
| 1 | +$181M | |
| 2 | +$172M | |
| 3 | +$143M | |
| 4 |
VI
Versor Investments
New York
|
+$69M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$61.6M |
Top Sellers
| 1 | -$174M | |
| 2 | -$126M | |
| 3 | -$92.4M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$90.5M |
| 5 |
BlackRock
New York
|
-$74.1M |